<DOC>
	<DOC>NCT01526863</DOC>
	<brief_summary>The aim of this trial is to assess the effect of hydrolyzed egg orally administered on oral tolerance induction to egg in children allergic to egg as compared to a placebo.</brief_summary>
	<brief_title>Hydrolyzed Egg and Tolerance Induction</brief_title>
	<detailed_description />
	<criteria>Child of any ethnicity aged between 12 and 66 months at the time of enrolment Positive Skin Prick Test (SPT) to egg white within the last 3 months Either positive oral challenge OR convincing history, defined as an immediate (&lt;1h) reaction following isolated ingestion of egg, positive SPT to egg white and positive sIgE (&gt; 0.35 kU/L) for at least one of the following: egg, egg white, ovalbumin, ovomucoid, within the last 12 months Having obtained his/her signed legal representative's informed consent. History of severe anaphylaxis to egg Significant prenatal and/or postnatal disease Child on systemic drugs (e.g. antihistamines, betaagonists, ACEinhibitors) according to halflife at time of enrolment Congenital illness or malformation that may affect normal growth (especially immunodeficiency) Child whose parents / caregivers cannot be expected to comply with treatment Child currently participating in another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>66 Months</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Egg</keyword>
</DOC>